Quest Diagnostics, Inc. (DGX) Misses Q1 EPS by 14c; Sees Slightly Weaker FY13 Revenue
Tweet Send to a Friend
Quest Diagnostics, Inc. (NYSE: DGX) reported Q1 EPS of $0.89, $0.14 worse than the analyst estimate of $1.03. Revenue for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
